Advertisement

The Scientist

» rare diseases, immunology and ecology

Most Recent

image: Owl Be Darned

Owl Be Darned

By | December 4, 2015

Researchers studying city-dwelling birds are learning about which animals are more suited to urban life.

1 Comment

image: A Rainforest Chorus

A Rainforest Chorus

By | December 1, 2015

Researchers measure the health of Papua New Guinea’s forests by analyzing the ecological soundscape.

0 Comments

image: Jungle Field Trip

Jungle Field Trip

By | December 1, 2015

Travel to remote rain forests in Papua New Guinea with researchers from The Nature Conservancy who are working with native people to characterize ecosystems there using sound.

0 Comments

image: Urban Owl-Fitters

Urban Owl-Fitters

By | December 1, 2015

How birds with an innate propensity for living among humans are establishing populations in cities

0 Comments

image: Spiders, Prey Leave DNA

Spiders, Prey Leave DNA

By | November 30, 2015

A study of black widow spiders suggests that the arachnids leave traces of their own genetic material and DNA from prey in their sticky webs.

0 Comments

image: Ebola’s Effects on the Eye

Ebola’s Effects on the Eye

By | November 30, 2015

A second doctor shows symptoms of ocular disease after recovering from Ebola infection.

0 Comments

image: Birth of the Skin Microbiome

Birth of the Skin Microbiome

By | November 17, 2015

The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

0 Comments

image: Microbes Play Role in Anti-Tumor Response

Microbes Play Role in Anti-Tumor Response

By | November 5, 2015

Gut microbiome composition can influence the effectiveness of cancer immunotherapy in mice.

1 Comment

image: Ebola’s Immune Escape

Ebola’s Immune Escape

By | November 3, 2015

The virus can persist in several tissues where the immune system is less active. Researchers are working to better understand this phenomenon and how it can stall the clearing of Ebola in survivors.

1 Comment

image: Shire Buys Rare Disease Drug Developer

Shire Buys Rare Disease Drug Developer

By | November 2, 2015

The Irish drugmaker is set to acquire the Massachusetts-based Dyax in a $5.9 billion deal.

0 Comments

Advertisement
Lonza Group
Lonza Group

Popular Now

  1. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  2. First Data from Anti-Aging Gene Therapy
  3. Locating Language within the Brain
  4. A Scrambled Mess
    Features A Scrambled Mess

    Why do so many human eggs have the wrong number of chromosomes?

Advertisement
SomaLogic
SomaLogic
Advertisement
RayBioTech